[Value of an anxiospasmolytic combination in colonic diseases and dyspepsia].
D000328:Adult; D001285:Atropine / Q000627:therapeutic use*; D002396:Catechols / Q000627:therapeutic use; D003092:Colitis / Q000188:drug therapy; D003108:Colonic Diseases / Q000188:drug therapy*; D004415:Dyspepsia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010080:Oxazoles / Q000627:therapeutic use; D010195:Pancreatitis / Q000188:drug therapy; D010437:Peptic Ulcer / Q000188:drug therapy; D011178:Postgastrectomy Syndromes / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D002396:Catechols; D010080:Oxazoles; D014149:Tranquilizing Agents; D001285:Atropine
Intérêt d'une association anxiospasmolytique dans les colopathies et les dyspepsies.